Literature DB >> 18755651

[2008 Update of Standards, Options: recommendations for management of patients with salivary gland malignant tumours (excluding lymphoma, sarcoma and melanoma), summary report].

René-Jean Bensadoun1, Olivier Dassonville, Sophie Rousmans.   

Abstract

The << Standards, Options : Recommendations >> (SOR) project has been undertaken by the French National Federation of Cancer Centers (FNCLCC) is now part of the French National Cancer Institute. The project involves the development and updating of evidence-based Clinical Practice Guidelines (CPG) in oncology. This paper is a summary version of the full clinical practice guideline presenting the updated recommendations for management of patients with salivary gland malignant tumours. Recommendations on radiotherapy have been updated to underline new Options on more and more accessible emerging techniques including intensity-modulated radiotherapy, 3D conformational radiotherapy, Cyberknife, tomotherapy, protontherapy and particle accelerators producing carbon ions (e.g. last generation hadrontherapy).

Entities:  

Mesh:

Year:  2008        PMID: 18755651     DOI: 10.1684/bdc.2008.0677

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

Review 1.  Supportive care treatment guidelines: value, limitations, and opportunities.

Authors:  Douglas E Peterson; Rene-Jean Bensadoun; Rajesh V Lalla; Deborah B McGuire
Journal:  Semin Oncol       Date:  2011-06       Impact factor: 4.929

2.  Massive multinodular head and neck recurrence of parotid gland pleomorphic adenoma: a case report.

Authors:  Pierre Philouze; Nicolas Sigaux; Anne Frédérique Manichon; Jean-Christian Pignat; Marc Poupart
Journal:  Case Rep Otolaryngol       Date:  2014-06-22

3.  Facial Nerve Monitoring During Parotidectomy:A Two-Center Retrospective Study.

Authors:  Stanislas Ballivet-de Régloix; Julia Grinholtz-Haddad; Olga Maurin; Louise Genestier; Quentin Lisan; Yoann Pons
Journal:  Iran J Otorhinolaryngol       Date:  2016-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.